Abstract
Older adults with advanced cognitive impairment have a limited life expectancy and the use of multiple drugs is of questionable benefit in this population. The aim of the present study was to assess if, in a sample of nursing home (NH) residents with advanced cognitive impairment, the effect of polypharmacy on mortality differs depending on estimated life expectancy.
Lingua originale | English |
---|---|
pagine (da-a) | 450.e7-450.e7-12 |
Rivista | Journal of the American Medical Directors Association |
Volume | 14 |
DOI | |
Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- Adrenergic beta-Antagonists
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
- Benzodiazepines
- Cardiotonic Agents
- Cognition Disorders
- Digoxin
- Drug Utilization
- European Union
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Israel
- Life Expectancy
- Male
- Nursing Homes
- Polypharmacy